Notably, in our GSCs‐Luc2 mouse xenograft model, B7 exhibited excellent anti‐glioma properties through selective intra‐tumoral NK cell accumulation via an immunostimulatory mechanism, making the first demonstration of the pivotal role of B7 in targeting NK cell‐linked TIME in gliomas. The gene discussed is CD80; the disease is central nervous system cancer.